Singapore markets open in 8 hours 53 minutes

Aurinia Pharmaceuticals Inc. (AUPH)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.160.00 (0.00%)
As of 12:03PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
191,407
175,513
134,030
45,605
50,118
Cost of revenue
21,479
14,148
5,664
1,091
0
Gross profit
169,928
161,365
128,366
44,514
50,118
Operating expenses
Research development
42,034
49,641
44,988
51,139
50,327
Selling general and administrative
193,587
195,036
196,371
173,536
97,272
Total operating expenses
238,605
253,056
239,836
225,249
154,408
Operating income or loss
-68,677
-91,691
-111,470
-180,735
-104,290
Interest expense
4,058
2,775
0
0
-
Total other income/expenses net
-
-
-
-
-6,809
Income before tax
-61,709
-77,469
-106,352
-180,206
-102,774
Income tax expense
854
551
1,828
760
-94
Income from continuing operations
-62,563
-78,020
-108,180
-180,966
-102,680
Net income
-62,563
-78,020
-108,180
-180,966
-102,680
Net income available to common shareholders
-62,563
-78,020
-108,180
-180,966
-102,680
Basic EPS
-0.54
-0.54
-0.76
-1.40
-0.87
Diluted EPS
-0.54
-0.54
-0.76
-1.40
-0.87
Basic average shares
142,856
143,236
141,915
129,369
118,473
Diluted average shares
142,856
143,236
141,915
129,369
118,473